Home/Pipeline/Eliquis (apixaban)

Eliquis (apixaban)

Atrial fibrillation

CommercialApproved

Key Facts

Indication
Atrial fibrillation
Phase
Commercial
Status
Approved
Company

About Bristol Myers Squibb

Bristol Myers Squibb operates as a premier global biopharmaceutical company with a mission to transform patients' lives through science. The company maintains leadership positions in oncology, hematology, cardiovascular, and immunology therapeutic areas with blockbuster products and innovative treatment modalities. BMS employs a research strategy rooted in causal human biology and diverse platform technologies to deliver first- and best-in-class medicines to patients worldwide.

View full company profile